PR Newswire: Health

PR Newswire: Health http://www.prnewswire.co.uk/cgi/news/topic?id=699 Health Press releases distributed via PR Newswire. hourly 5 2005-01-01T00:00+00:00 PR Newswire Europe Ltd. Copyright © 1996-2008 PR Newswire Europe Ltd. All Rights Reserved. en-US 2009-11-20T20:18:03+00:00 PR Newswire: Health http://www.prnewswire.com/global/homepage/images/logo.gif http://www.prnewswire.co.uk/cgi/news/topic?id=699 Opération internationale pour combattre la vente en ligne de medicaments de contrefaçon et illégaux http://www.prnewswire.co.uk/cgi/news/release?id=272590 2009-11-20T20:13:00+0000 Internationale Operation gegen den Online-Verkauf von gefälschten und illegalen Arzneimitteln http://www.prnewswire.co.uk/cgi/news/release?id=272586 2009-11-20T19:25:00+0000 Operación internacional para luchar contra el suministro online de medicamentos falsificados e ilegales http://www.prnewswire.co.uk/cgi/news/release?id=272555 2009-11-20T11:59:00+0000 Marktzulassungsantrag für S-1 von der Europäischen Arzneimittelagentur genehmigt http://www.prnewswire.co.uk/cgi/news/release?id=272541 2009-11-20T10:38:00+0000 Solicitud de autorización de marketing para S-1 validada por la Agencia Europea del Medicamento http://www.prnewswire.co.uk/cgi/news/release?id=272537 2009-11-20T08:43:00+0000 Karolinska Development och European Investment Fund Startar Banbrytande Fond för Saminvesteringar Inom Läkemedelsutveckling http://www.prnewswire.co.uk/cgi/news/release?id=272530 2009-11-20T08:00:00+0000 Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation http://www.prnewswire.co.uk/cgi/news/release?id=272531 2009-11-20T08:00:00+0000 Découvrez Icon, la révolution dans le traitement de la carie dentaire http://www.prnewswire.co.uk/cgi/news/release?id=272535 2009-11-20T08:00:00+0000 International Operation Combats Online Supply of Counterfeit and Illegal Medicines http://www.prnewswire.co.uk/cgi/news/release?id=272515 2009-11-20T02:29:00+0000 La demande d'autorisation de mise sur le marché du S-1 est validée par l'Agence européenne des médicaments http://www.prnewswire.co.uk/cgi/news/release?id=272514 2009-11-20T02:23:00+0000 L'étude POPular met en avant le système VerifyNow(R) en matière de test de réactivité plaquettaire http://www.prnewswire.co.uk/cgi/news/release?id=272484 2009-11-19T20:28:00+0000 Das VerifyNow(R)-System wurde in der POPular-Vergleichsstudie von Thrombozytenaggregations-Reaktionstests herausgestellt http://www.prnewswire.co.uk/cgi/news/release?id=272483 2009-11-19T20:21:00+0000 Uni.H.A. in Frankreich unterzeichnet Kaufvereinbarung für Masimo SET(R) Pulsoximetrieprodukte http://www.prnewswire.co.uk/cgi/news/release?id=272480 2009-11-19T19:50:00+0000 Uni.H.A. en France signe un contrat d'achat pour les produits d'oxymétrie de pouls Masimo SET(R) http://www.prnewswire.co.uk/cgi/news/release?id=272478 2009-11-19T19:46:00+0000 El sistema VerifyNow(R) destaca el estudio POPular que compara los restos de reactividad de las plaquetas http://www.prnewswire.co.uk/cgi/news/release?id=272476 2009-11-19T19:40:00+0000 Marketing Authorisation Application for S-1 Validated by European Medicines Agency http://www.prnewswire.co.uk/cgi/news/release?id=272468 2009-11-19T18:26:00+0000 Procter & Gamble ruft freiwillig bestimmte chargen vonsinex schnupfenspray in Deutschland; Grossbritannien und den USA Zurück http://www.prnewswire.co.uk/cgi/news/release?id=272467 2009-11-19T18:24:00+0000 Photos: P&G Voluntarily Recalls Specific Lots of Vicks Sinex Nasal Spray in the United States, Germany and the United Kingdom http://www.prnewswire.co.uk/cgi/news/release?id=272466 2009-11-19T18:22:00+0000 Medicines Top Counterfeit Concern List in Europe - Consumers Call for Tougher Safety Measures http://www.prnewswire.co.uk/cgi/news/release?id=272441 2009-11-19T16:10:00+0000 Angst vor Fälschungen: Medikamente in Deutschland an erster Stelle - Verbraucher verlangen strengere Sicherheitsmassnahmen http://www.prnewswire.co.uk/cgi/news/release?id=272443 2009-11-19T16:01:00+0000 VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests http://www.prnewswire.co.uk/cgi/news/release?id=272410 2009-11-19T13:30:00+0000 Visage Imaging Signs University of Chicago http://www.prnewswire.co.uk/cgi/news/release?id=272370 2009-11-19T08:00:00+0000 Menicon übernimmt britischen Kontaktlinsenhersteller David Thomas Contact Lenses Ltd. http://www.prnewswire.co.uk/cgi/news/release?id=272359 2009-11-19T06:56:00+0000 Metabolische Auswirkungen bei Behandlung von Patienten mit Schizophrenie mit INVEGA(R) deutlich niedriger als bei oraler Verabreichung von Olanzapin http://www.prnewswire.co.uk/cgi/news/release?id=272357 2009-11-19T06:19:00+0000 Menicon to Acquire David Thomas Contact Lenses Ltd., Major U.K. Custom Lens Manufacturer http://www.prnewswire.co.uk/cgi/news/release?id=272345 2009-11-19T05:00:00+0000 Menicon adquirirá David Thomas Contact Lenses Ltd., el mayor fabricante británico de lentes a medida http://www.prnewswire.co.uk/cgi/news/release?id=272346 2009-11-19T05:00:00+0000 Menicon fera l'acquisition de David Thomas Contact Lenses Ltd., un important fabricant de lentilles sur mesure au Royaume-Uni http://www.prnewswire.co.uk/cgi/news/release?id=272347 2009-11-19T05:00:00+0000 Menicon neemt David Thomas Contact Lenses Ltd. over, een grote Britse lenzenfabrikant http://www.prnewswire.co.uk/cgi/news/release?id=272348 2009-11-19T05:00:00+0000 Selon Apieron, les preuves démontrent que les inventeurs d'Aerocrine n'ont pas divulgué des informations d'art au Bureau des brevets http://www.prnewswire.co.uk/cgi/news/release?id=272334 2009-11-18T23:22:00+0000 Apieron beruft sich auf Beweismittel, die zeigen, dass Aerocrines Erfinder dem Patentamt Informationen über den neuesten Stand der Technik vorenthalten haben http://www.prnewswire.co.uk/cgi/news/release?id=272333 2009-11-18T23:15:00+0000 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products http://www.prnewswire.co.uk/cgi/news/release?id=272317 2009-11-18T20:00:00+0000 /C O R R E C T I O N -- Teva UK Ltd/ http://www.prnewswire.co.uk/cgi/news/release?id=272316 2009-11-18T19:39:00+0000 Los efectos metabólicos se reducen significativamente con INVEGA(R) en la esquizofrenia http://www.prnewswire.co.uk/cgi/news/release?id=272315 2009-11-18T19:32:00+0000 INVEGA(R) réduit considérablement les effets métaboliques par rapport à l'olanzapine orale chez les patients atteints de schizophrénie http://www.prnewswire.co.uk/cgi/news/release?id=272314 2009-11-18T19:31:00+0000 La EPOC afecta sobre todo al pilar de la fuerza de trabajo mundial (personas de entre 40 y 65 años) http://www.prnewswire.co.uk/cgi/news/release?id=272301 2009-11-18T17:48:00+0000 La principale tranche démographique de la main d'oeuvre mondiale - les personnes âgées de 40 à 65 ans - est la plus sévèrement touchée par la broncho-pneumopathie obstructive chronique (BPCO) http://www.prnewswire.co.uk/cgi/news/release?id=272302 2009-11-18T17:48:00+0000 Albireo gibt positive klinische Ergebnisse mit A3309 bei Patienten mit chronischer idiopathischer Konstipation bekannt http://www.prnewswire.co.uk/cgi/news/release?id=272300 2009-11-18T17:38:00+0000 Albireo annuncia dati clinici positivi su A3309 in pazienti con costipazione idiopatica cronica http://www.prnewswire.co.uk/cgi/news/release?id=272299 2009-11-18T17:36:00+0000 Ny nedkylningsmetod vid hjärtstopp kan rädda fler hjärnor under hjärtstillestånd http://www.prnewswire.co.uk/cgi/news/release?id=272294 2009-11-18T16:55:00+0000 Una fascia importantissima della forza lavoro - le persone tra i 40 e i 65 anni - è la più colpita dalla broncopneumopatia cronica ostruttiva (BPCO) http://www.prnewswire.co.uk/cgi/news/release?id=272289 2009-11-18T15:44:00+0000 Die Stütze des weltweiten Erwerbsbevölkerung - die Gruppe der 40- bis 65-Jährigen - ist am stärksten von der chronisch-obstruktiven Lungenerkrankung (COPD) betroffen http://www.prnewswire.co.uk/cgi/news/release?id=272288 2009-11-18T15:40:00+0000 Scientific Pioneer Lectures on AcceleDent Science in Key United Kingdom Orthodontic Venues http://www.prnewswire.co.uk/cgi/news/release?id=272285 2009-11-18T15:22:00+0000 Apieron alega que Aerocrine poseían información no mostrada a la oficina de patentes http://www.prnewswire.co.uk/cgi/news/release?id=272279 2009-11-18T14:26:00+0000 Health Robotics Announces Worldwide Launch of the "i.v. Room of the Future" Concept at Las Vegas' ASHP http://www.prnewswire.co.uk/cgi/news/release?id=272269 2009-11-18T14:00:00+0000 Les données d'essais de << Destination Therapy >> démontrent la supériorité de HeartMate II(R) sur HeartMate(R) XVE http://www.prnewswire.co.uk/cgi/news/release?id=272253 2009-11-18T12:40:00+0000 /C O R R E C T I O N -- Education for Health/ http://www.prnewswire.co.uk/cgi/news/release?id=272245 2009-11-18T11:41:00+0000 Apieron Alleges Evidence Shows Aerocrine Inventors Withheld Prior Art Information from Patent Office http://www.prnewswire.co.uk/cgi/news/release?id=272236 2009-11-18T11:00:00+0000 H1N1-Impfstoff von Mellow Hope und Hard To Treat Diseases (HTDS) erhält Zulassung in Chile http://www.prnewswire.co.uk/cgi/news/release?id=272166 2009-11-18T08:00:00+0000 Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation http://www.prnewswire.co.uk/cgi/news/release?id=272176 2009-11-18T08:00:00+0000 Albireo anuncia datos clínicos positivos sobre el A3309 en pacientes con estreñimiento idiopático crónico http://www.prnewswire.co.uk/cgi/news/release?id=272178 2009-11-18T08:00:00+0000 Albireo annonce des données cliniques positives pour l'A3309 chez les patients atteints de constipation idiopathique chronique http://www.prnewswire.co.uk/cgi/news/release?id=272179 2009-11-18T08:00:00+0000 Hard To Treat Diseases (HTDS) Mellow Hope's H1N1 Influenza A Vaccine Successful Registration in Chile http://www.prnewswire.co.uk/cgi/news/release?id=272182 2009-11-18T08:00:00+0000 Hard To Treat Diseases (HTDS) : Mellow Hope obtient le feu vert pour son vaccin contre la grippe A (H1N1) au Chili http://www.prnewswire.co.uk/cgi/news/release?id=272183 2009-11-18T08:00:00+0000 Varian Medical Systems présentera ses derniers détecteurs d'images à rayons X et tubes à rayons X à l'occasion de la foire commerciale internationale MEDICA 2009 http://www.prnewswire.co.uk/cgi/news/release?id=272143 2009-11-18T07:00:00+0000 Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair http://www.prnewswire.co.uk/cgi/news/release?id=272146 2009-11-18T07:00:00+0000 Teva Launches TevaGrastim(R) (filgrastim) http://www.prnewswire.co.uk/cgi/news/release?id=272150 2009-11-18T07:00:00+0000 Varian Medical Systems stellt auf der internationalen Fachmesse MEDICA 2009 die jüngsten Röntgenröhren und Bildgebungsdetektoren des Unternehmens vor http://www.prnewswire.co.uk/cgi/news/release?id=272153 2009-11-18T07:00:00+0000 Varian presentará los últimos detectores de imágenes de rayos X y tubos de rayos x en MEDICA 2009 http://www.prnewswire.co.uk/cgi/news/release?id=272155 2009-11-18T07:00:00+0000 Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD) http://www.prnewswire.co.uk/cgi/news/release?id=272141 2009-11-18T06:30:00+0000 New H1N1 Flu Test Available Now - On Display At MEDICA 2009 http://www.prnewswire.co.uk/cgi/news/release?id=272134 2009-11-18T06:00:00+0000 Le nouveau test pour la grippe H1N1 est maintenant disponible - présentation au Salon MEDICA 2009 http://www.prnewswire.co.uk/cgi/news/release?id=272135 2009-11-18T06:00:00+0000 Neuer H1N1-Grippetest ab sofort erhältlich - Präsentation auf der MEDICA 2009 http://www.prnewswire.co.uk/cgi/news/release?id=272136 2009-11-18T06:00:00+0000 Novo Teste para Gripe H1N1 Disponível Agora - em Exibição na MEDICA 2009 http://www.prnewswire.co.uk/cgi/news/release?id=272137 2009-11-18T06:00:00+0000 Ya está disponible un nuevo test para la gripe H1N1 - Se muestra en MEDICA 2009 http://www.prnewswire.co.uk/cgi/news/release?id=272138 2009-11-18T06:00:00+0000 AMT Provides Business Update for the Third Quarter 2009 http://www.prnewswire.co.uk/cgi/news/release?id=272140 2009-11-18T06:00:00+0000 Video: Crestor(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of Jupiter Study http://www.prnewswire.co.uk/cgi/news/release?id=272106 2009-11-17T21:34:00+0000 CRESTOR(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of Jupiter Study http://www.prnewswire.co.uk/cgi/news/release?id=272105 2009-11-17T21:00:00+0000 Dauertherapiestudie zeigt die Überlegenheit von HeartMate II(R) gegenüber HeartMate(R) XVE http://www.prnewswire.co.uk/cgi/news/release?id=272095 2009-11-17T19:47:00+0000 Le test de CD4 Zyomyx à utiliser sur le lieu d'intervention sélectionné par l'Initiative CD4 afin d'apporter un traitement aux patients atteints du VIH/sida dans les pays en voie de développement http://www.prnewswire.co.uk/cgi/news/release?id=272091 2009-11-17T18:43:00+0000 FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets http://www.prnewswire.co.uk/cgi/news/release?id=272077 2009-11-17T15:33:00+0000 Zyomyx PoC-CD4-Test erste Wahl der CD4-Initiative zur Behandlung von HIV/AIDS-Patienten in Entwicklungsländern http://www.prnewswire.co.uk/cgi/news/release?id=272075 2009-11-17T15:16:00+0000 Destination Therapy Trial Data Demonstrate Superiority for HeartMate II(R) Over HeartMate(R) XVE http://www.prnewswire.co.uk/cgi/news/release?id=272036 2009-11-17T13:00:00+0000 Cover for Gap Year Travellers Essential, Says Go Travel Insurance http://www.prnewswire.co.uk/cgi/news/release?id=272013 2009-11-17T10:43:00+0000 LightSleeper(R), a Bedside Electronic Sleep Aid is Hotly Tipped to be a Ground-Breaking Solution for Anyone who has Problems Sleeping http://www.prnewswire.co.uk/cgi/news/release?id=271994 2009-11-17T09:00:00+0000 El nuevo consorcio lidera el camino para el tratamiento mejorado de la hipertensión http://www.prnewswire.co.uk/cgi/news/release?id=271969 2009-11-17T08:00:00+0000 New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications http://www.prnewswire.co.uk/cgi/news/release?id=271976 2009-11-17T08:00:00+0000 Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries http://www.prnewswire.co.uk/cgi/news/release?id=271982 2009-11-17T08:00:00+0000 Neues Konsortium ebnet den Weg für verbesserte Behandlung von Hypertonie und damit in Zusammenhang stehende Gefässkomplikationen http://www.prnewswire.co.uk/cgi/news/release?id=271984 2009-11-17T08:00:00+0000 Un nouveau consortium ouvre la voie au traitement amélioré de l'hypertension et des complications vasculaires associées http://www.prnewswire.co.uk/cgi/news/release?id=271985 2009-11-17T08:00:00+0000 US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine http://www.prnewswire.co.uk/cgi/news/release?id=271992 2009-11-17T08:00:00+0000 Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial http://www.prnewswire.co.uk/cgi/news/release?id=271940 2009-11-16T20:00:00+0000 Une nouvelle méthode de refroidissement en arrêt cardiaque pourrait contribuer à la préservation des cellules cérébrales http://www.prnewswire.co.uk/cgi/news/release?id=271929 2009-11-16T18:47:00+0000 Sanofi-aventis lance un nouveau registre majeur incluant plus de 10 000 patients souffrant de Fibrillation Atriale dans le monde http://www.prnewswire.co.uk/cgi/news/release?id=271922 2009-11-16T17:09:00+0000 Sanofi-aventis Launches Major New Registry Including Over 10,000 Patients Worldwide With Atrial Fibrillation http://www.prnewswire.co.uk/cgi/news/release?id=271921 2009-11-16T17:00:00+0000 ThromboGenics and BioInvent Complete Phase I Patient Trial of Anti-PlGF Cancer Therapeutic TB-403 in Patients With Advanced Solid Tumours http://www.prnewswire.co.uk/cgi/news/release?id=271920 2009-11-16T16:45:00+0000 Neues Kühlverfahren rettet potenziell Hirnfunktionen über einen Herzkreislaufstillstand hinweg http://www.prnewswire.co.uk/cgi/news/release?id=271919 2009-11-16T16:31:00+0000 El nuevo método de enfriamiento de intra-paros podría salvar más cerebros durante paradas cardíacas http://www.prnewswire.co.uk/cgi/news/release?id=271909 2009-11-16T14:13:00+0000 Paloma Pharmaceuticals präsentiert auf der Internationalen Konferenz zu Molekulartargets und Krebstherapien AACR-NCI-EORTC http://www.prnewswire.co.uk/cgi/news/release?id=271898 2009-11-16T14:00:00+0000 Paloma Pharmaceuticals donne une présentation à la conference internationale AACR-NCI-EORTC : cibles moléculaires et traitements contre le cancer http://www.prnewswire.co.uk/cgi/news/release?id=271899 2009-11-16T14:00:00+0000 Presentación de Paloma Pharmaceuticals http://www.prnewswire.co.uk/cgi/news/release?id=271900 2009-11-16T14:00:00+0000 Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics http://www.prnewswire.co.uk/cgi/news/release?id=271908 2009-11-16T14:00:00+0000 Flibanserin Demonstrates Efficacy and Tolerability in Pivotal Phase III Trials in Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD) http://www.prnewswire.co.uk/cgi/news/release?id=271890 2009-11-16T13:00:00+0000 Medical Doctors Confirm "Divine Healing" Cases at the 6th International Christian Medical Conference http://www.prnewswire.co.uk/cgi/news/release?id=271864 2009-11-16T09:50:00+0000 Frost & Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market http://www.prnewswire.co.uk/cgi/news/release?id=271842 2009-11-16T08:00:00+0000 ALK Announces Landmark Asthma Prevention Trial http://www.prnewswire.co.uk/cgi/news/release?id=271847 2009-11-16T08:00:00+0000 ALK- ABELLÓ anuncia el inicio de un estudio para la prevención del asma http://www.prnewswire.co.uk/cgi/news/release?id=271851 2009-11-16T08:00:00+0000 ALK annonce une étude clinique novatrice dans la prévention de l'asthme http://www.prnewswire.co.uk/cgi/news/release?id=271852 2009-11-16T08:00:00+0000 ALK kündigt wegweisende Asthma-Präventionsstudie an http://www.prnewswire.co.uk/cgi/news/release?id=271853 2009-11-16T08:00:00+0000 Concuity Announces Next-Generation Revenue Cycle Management Solution http://www.prnewswire.co.uk/cgi/news/release?id=271825 2009-11-16T06:00:00+0000 New Intra-Arrest Cooling Method May Save More Brains During Cardiac Arrest http://www.prnewswire.co.uk/cgi/news/release?id=271818 2009-11-15T22:57:00+0000 First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes http://www.prnewswire.co.uk/cgi/news/release?id=271816 2009-11-15T21:00:00+0000 Efient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease http://www.prnewswire.co.uk/cgi/news/release?id=271811 2009-11-15T20:00:00+0000 IVT wird mobiles Gesundheitssystem auf dem GSMA Mobile Asia-Kongress sowie auf der CES 2010 vorführen http://www.prnewswire.co.uk/cgi/news/release?id=271803 2009-11-13T22:08:00+0000 IVT fera une démonstration du système de soins mobiles lors du Mobile Asia Congress de la GSMA et du CES 2010 http://www.prnewswire.co.uk/cgi/news/release?id=271802 2009-11-13T22:04:00+0000 IVT demostrará el sistema de salud móvil en el congreso GSMA Mobile Asia y CES 2010 http://www.prnewswire.co.uk/cgi/news/release?id=271789 2009-11-13T16:57:00+0000 /C O R R E C T I O N -- Scope Dental Professional Relations/ http://www.prnewswire.co.uk/cgi/news/release?id=271785 2009-11-13T15:25:00+0000 Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor http://www.prnewswire.co.uk/cgi/news/release?id=271776 2009-11-13T14:00:00+0000 IVT will Demo Mobile Health System at GSMA Mobile Asia Congress and CES 2010 http://www.prnewswire.co.uk/cgi/news/release?id=271773 2009-11-13T13:34:00+0000 Coventry - Mouth Cancer Screening at Local Dental Practice http://www.prnewswire.co.uk/cgi/news/release?id=271767 2009-11-13T12:05:00+0000 West Bromwich - Mouth Cancer Screening at Local Dental Practice http://www.prnewswire.co.uk/cgi/news/release?id=271766 2009-11-13T11:49:00+0000 Mouth London - Cancer Screening at Local Dental Practice http://www.prnewswire.co.uk/cgi/news/release?id=271764 2009-11-13T11:48:00+0000 Cosmetic Surgeons Refer 20% of Patients to Psychologists http://www.prnewswire.co.uk/cgi/news/release?id=271753 2009-11-13T08:50:00+0000 Le test ProFlu-ST(TM) de Prodesse reçoit la marque européenne CE http://www.prnewswire.co.uk/cgi/news/release?id=271730 2009-11-12T20:03:00+0000 Der ProFlu-ST(TM)-Assay von Prodesse erhält CE-Kennzeichnung in Europa http://www.prnewswire.co.uk/cgi/news/release?id=271728 2009-11-12T19:59:00+0000 Bluestar Silicones sera présent pour la première fois au Salon MEDICA 2009 à Düsseldorf afin de présenter ses produits Silbione(R) http://www.prnewswire.co.uk/cgi/news/release?id=271706 2009-11-12T15:38:00+0000 Bluestar Silicones stellt erstmalig auf der MEDICA Messe 2009 in Düsseldorf aus, um die Silbione(R) Difference vorzustellen http://www.prnewswire.co.uk/cgi/news/release?id=271705 2009-11-12T15:35:00+0000 Bluestar Silicones to Make its Debut at MEDICA 2009 in Düsseldorf to Showcase the Silbione(R) Difference http://www.prnewswire.co.uk/cgi/news/release?id=271704 2009-11-12T15:33:00+0000 Health Robotics Reaches 100% Asia-Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea http://www.prnewswire.co.uk/cgi/news/release?id=271697 2009-11-12T14:00:00+0000 El ensayo ProFlu-ST(TM) de Prodesse recibe la Marca CE europea http://www.prnewswire.co.uk/cgi/news/release?id=271691 2009-11-12T13:41:00+0000 Le bêta-carotène est une source de vitamine A indispensable et sûre http://www.prnewswire.co.uk/cgi/news/release?id=271686 2009-11-12T13:32:00+0000 Mersana Therapeutics publie un article de périodique qui expose en détail les avantages de son principal médicament anticancéreux dans le journal Advanced Drug Delivery Reviews http://www.prnewswire.co.uk/cgi/news/release?id=271670 2009-11-12T12:00:00+0000 Mersana Therapeutics veröffentlicht im Journal of Advanced Drug Delivery Reviews einen Übersichtsartikel, in dem die Vorteile der führenden Krebsverbindung des Unternehmens im Einzelnen dargestellt werden http://www.prnewswire.co.uk/cgi/news/release?id=271671 2009-11-12T12:00:00+0000 Mersana Therapeutics Publishes Review Article Detailing Advantages of its Lead Cancer Compound in Journal of Advanced Drug Delivery Reviews http://www.prnewswire.co.uk/cgi/news/release?id=271672 2009-11-12T12:00:00+0000 Mersana Therapeutics publica un artículo de revisión detallando las ventajas de su compuesto de cáncer http://www.prnewswire.co.uk/cgi/news/release?id=271673 2009-11-12T12:00:00+0000 Tobira Therapeutics stellt auf der European AIDS Conference Ergebnisse mit TBR-652 vor http://www.prnewswire.co.uk/cgi/news/release?id=271652 2009-11-12T11:00:00+0000 Tobira Therapeutics annonce la présentation des données portant sur TBR-652 à l'occasion de la conférence européenne sur le SIDA http://www.prnewswire.co.uk/cgi/news/release?id=271654 2009-11-12T11:00:00+0000 Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference http://www.prnewswire.co.uk/cgi/news/release?id=271655 2009-11-12T11:00:00+0000 ZS Associates eröffnet Niederlassung in Spanien http://www.prnewswire.co.uk/cgi/news/release?id=271625 2009-11-12T09:13:00+0000 ZS Associates ouvre un bureau en Espagne http://www.prnewswire.co.uk/cgi/news/release?id=271624 2009-11-12T09:11:00+0000 ZS Associates Opens Spain Office http://www.prnewswire.co.uk/cgi/news/release?id=271622 2009-11-12T09:06:00+0000 ZS Associates abre una oficina en España http://www.prnewswire.co.uk/cgi/news/release?id=271627 2009-11-12T08:00:00+0000 Prodesse's ProFlu-ST(TM) Assay Receives European CE Mark http://www.prnewswire.co.uk/cgi/news/release?id=271603 2009-11-12T07:00:00+0000 La sensibilisation à l'hypoglycémie : une arme essentielle à la lutte contre le diabète http://www.prnewswire.co.uk/cgi/news/release?id=271578 2009-11-12T00:01:00+0000 Formación sobre la hipoglicemia - Un arma vital en la lucha para ganar a la diabetes http://www.prnewswire.co.uk/cgi/news/release?id=271580 2009-11-12T00:01:00+0000 Hypoglycemia Education - A Vital Weapon in the Battle to Conquer Diabetes http://www.prnewswire.co.uk/cgi/news/release?id=271614 2009-11-12T00:01:00+0000 Hypoglykämie-Schulung - eine entscheidende Waffe im Kampf gegen Diabetes http://www.prnewswire.co.uk/cgi/news/release?id=271623 2009-11-12T00:01:00+0000 Nutrition Security for Children in Bangladesh http://www.prnewswire.co.uk/cgi/news/release?id=271573 2009-11-11T23:00:00+0000 Voltz Appoints Australian Distributor for Voltz Energy Shot Drink http://www.prnewswire.co.uk/cgi/news/release?id=271570 2009-11-11T21:00:00+0000 Estudio en The Lancet Oncology muestra que la capecitabina reduce la reaparición del cáncer de mama http://www.prnewswire.co.uk/cgi/news/release?id=271556 2009-11-11T17:05:00+0000 Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 September 2009 http://www.prnewswire.co.uk/cgi/news/release?id=271538 2009-11-11T13:41:00+0000 La GSMA y la University of Manchester establecerán un m-Health Innovation Centre http://www.prnewswire.co.uk/cgi/news/release?id=271536 2009-11-11T13:08:00+0000 Nouveau champion du monde des poids lourds de boxe à peine marqué http://www.prnewswire.co.uk/cgi/news/release?id=271499 2009-11-11T09:00:00+0000 Barely a Bruise on New World Heavyweight Boxing Champion http://www.prnewswire.co.uk/cgi/news/release?id=271501 2009-11-11T09:00:00+0000 Neanche un livido per il nuovo campione del mondo di pugilato dei pesi massimi http://www.prnewswire.co.uk/cgi/news/release?id=271502 2009-11-11T09:00:00+0000 GSMA and the University of Manchester to Establish an m-Health Innovation Centre http://www.prnewswire.co.uk/cgi/news/release?id=271504 2009-11-11T09:00:00+0000 Des travaux de recherche sur le logiciel PROcedure Rehearsal de Simbionix récompensés par le prix Magna Cum Laude à CIRSE 2009 http://www.prnewswire.co.uk/cgi/news/release?id=271505 2009-11-11T09:00:00+0000 Forschungen an Simbionix PROcedure Rehearsal Software bei der CIRSE 2009 mit dem "Magna Cum Laude"-Preis ausgezeichnet http://www.prnewswire.co.uk/cgi/news/release?id=271506 2009-11-11T09:00:00+0000 GSMA und die Universität Manchester gründen einen m-Health-Innovationscenter http://www.prnewswire.co.uk/cgi/news/release?id=271507 2009-11-11T09:00:00+0000 Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009 http://www.prnewswire.co.uk/cgi/news/release?id=271508 2009-11-11T09:00:00+0000 Kaum ein blauer Fleck am neuen Boxweltmeister im Schwergewicht http://www.prnewswire.co.uk/cgi/news/release?id=271509 2009-11-11T09:00:00+0000 Frost & Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market, the Golden Standard in Patient Safety http://www.prnewswire.co.uk/cgi/news/release?id=271510 2009-11-11T09:00:00+0000 Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R)) Combination Therapy Reduces Early Breast Cancer Recurrence http://www.prnewswire.co.uk/cgi/news/release?id=271492 2009-11-11T08:00:00+0000 realbuzz.com Top Tips to Cut the Calories This Christmas Party Season http://www.prnewswire.co.uk/cgi/news/release?id=271470 2009-11-11T06:30:00+0000 AMT Successful in Preclinical Treatment of DMD http://www.prnewswire.co.uk/cgi/news/release?id=271464 2009-11-11T06:00:00+0000 CSafe Adopts the New IATA Regulation for Healthcare Cargo http://www.prnewswire.co.uk/cgi/news/release?id=271387 2009-11-10T14:17:00+0000 Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan http://www.prnewswire.co.uk/cgi/news/release?id=271360 2009-11-10T11:32:00+0000 Vocera Ships Its First Smartphone to Deliver Unified Communications in the Hospital Setting http://www.prnewswire.co.uk/cgi/news/release?id=271346 2009-11-10T09:00:00+0000 Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States http://www.prnewswire.co.uk/cgi/news/release?id=271337 2009-11-10T08:49:00+0000 Astellas Pharma Europe Announces Save the Children as a Winner of the Changing Tomorrow 2009 Awards http://www.prnewswire.co.uk/cgi/news/release?id=271304 2009-11-10T06:00:00+0000 Astellas Pharma Europe annonce que << Save the Children >> fait partie des lauréats des prix Changing Tomorrow 2009 Awards http://www.prnewswire.co.uk/cgi/news/release?id=271305 2009-11-10T06:00:00+0000 Astellas Pharma Europe anuncia Save the Children como ganador de los Changing Tomorrow 2009 Awards http://www.prnewswire.co.uk/cgi/news/release?id=271306 2009-11-10T06:00:00+0000 Astellas Pharma Europe gibt Save the Children als einen Gewinner des "Changing Tomorrow 2009 Awards" bekannt http://www.prnewswire.co.uk/cgi/news/release?id=271310 2009-11-10T06:00:00+0000 Novartis übernimmt für 125 Mio. USD Mehrheitsbeteiligung an der chinesischen H1N1-Impfstoff-Tochtergesellschaft von Hard to Treat Diseases (HTDS.PK) http://www.prnewswire.co.uk/cgi/news/release?id=271311 2009-11-10T06:00:00+0000 Novartis acquiert une participation majoritaire dans la filiale chinoise de Hard to Treat Diseases (HTDS.PK) associée dans la mise au point du vaccine contre la grippe H1N1 moyennant 125 millions USD http://www.prnewswire.co.uk/cgi/news/release?id=271301 2009-11-10T05:27:00+0000 Daval International erhält Orphan-Drug-Status für die Behandlung von Motorneuronenerkrankungen zugesprochen http://www.prnewswire.co.uk/cgi/news/release?id=271286 2009-11-09T22:24:00+0000 Daval International a obtenu la désignation de médicament orphelin pour son traitement contre la maladie des neurones moteurs http://www.prnewswire.co.uk/cgi/news/release?id=271285 2009-11-09T22:19:00+0000 Forecast Looks Good for India Pharma Shows http://www.prnewswire.co.uk/cgi/news/release?id=271281 2009-11-09T21:00:00+0000 Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million http://www.prnewswire.co.uk/cgi/news/release?id=271274 2009-11-09T19:30:00+0000 D-Pharm Enters Into Collaboration With Wanbang Biopharmaceuticals to Increase the Potential Market for its Stroke Drug-Candidate DP-b99 http://www.prnewswire.co.uk/cgi/news/release?id=271246 2009-11-09T13:00:00+0000 intendiX - Communication by Thoughts: First Patient-Ready System on the Market http://www.prnewswire.co.uk/cgi/news/release?id=271212 2009-11-09T09:00:00+0000 intendiX - La communication par la pensée : première BCI destinée aux patients sur le marché http://www.prnewswire.co.uk/cgi/news/release?id=271199 2009-11-09T08:00:00+0000 intendiX - Comunicación por pensamientos: primer sistema preparado para el paciente en el mercado http://www.prnewswire.co.uk/cgi/news/release?id=271204 2009-11-09T08:00:00+0000 Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment http://www.prnewswire.co.uk/cgi/news/release?id=271190 2009-11-09T07:00:00+0000 Daval International consigue la designación de fármaco huérfano para tratar las neuronas motoras http://www.prnewswire.co.uk/cgi/news/release?id=271191 2009-11-09T07:00:00+0000 See the Benefits of a Healthy Lifestyle http://www.prnewswire.co.uk/cgi/news/release?id=271173 2009-11-09T00:01:00+0000 Being Bothered About Employee Eye Health http://www.prnewswire.co.uk/cgi/news/release?id=271175 2009-11-09T00:01:00+0000 Zebinix a Novel Once Daily Anti-Epileptic Launched Today in the UK http://www.prnewswire.co.uk/cgi/news/release?id=271177 2009-11-09T00:01:00+0000 Money Worries put 75 per cent of Brits at Risk of Avoidable Sight Loss http://www.prnewswire.co.uk/cgi/news/release?id=271178 2009-11-09T00:01:00+0000 Obese Britain Blind to Risk of Sight Loss http://www.prnewswire.co.uk/cgi/news/release?id=271180 2009-11-09T00:01:00+0000 Helix BioPharma Corp. schliesst Aufnahme von Patienten mit anogenitalen Warzen in seine Phase-II-Studie zu Topical Interferon Alpha-2b ab http://www.prnewswire.co.uk/cgi/news/release?id=271163 2009-11-07T01:52:00+0000 Nouvelle technologie de codage laser pour les récipients pharmaceutiques en verre http://www.prnewswire.co.uk/cgi/news/release?id=271147 2009-11-06T17:43:00+0000 U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat http://www.prnewswire.co.uk/cgi/news/release?id=271142 2009-11-06T17:06:00+0000 Raptor Pharmaceutical Corporation annonce la présentation de données concernant le NGX426, un nouvel analgésique oral non opioïde, lors du Congrès sur la douleur neuropathique http://www.prnewswire.co.uk/cgi/news/release?id=271139 2009-11-06T16:02:00+0000 Handen, de belangrijkste overdrachtsroute bij infectieziektes http://www.prnewswire.co.uk/cgi/news/release?id=271134 2009-11-06T14:40:00+0000 Astellas Pharma Europe gibt bekannt, dass die International Foundation for Dermatology einer der Preisträger der Changing Tomorrow 2009 Awards ist http://www.prnewswire.co.uk/cgi/news/release?id=271132 2009-11-06T14:14:00+0000 Astellas Pharma Europe anuncia a la ganadora de los Changing Tomorrow 2009 Awards http://www.prnewswire.co.uk/cgi/news/release?id=271131 2009-11-06T14:11:00+0000 Astellas Pharma Europe annonce que la Fondation internationale de dermatologie fait partie des lauréats du concours Changing Tomorrow 2009 http://www.prnewswire.co.uk/cgi/news/release?id=271130 2009-11-06T14:09:00+0000 Mouth Cancer - A Deadly Disease - On the Increase http://www.prnewswire.co.uk/cgi/news/release?id=271128 2009-11-06T13:24:00+0000 Nueva tecnología de codificación por láser para contenedores farmacéuticos de vidrio http://www.prnewswire.co.uk/cgi/news/release?id=271114 2009-11-06T10:15:00+0000 NIGHTBRA, the First Anti-Wrinkle Bra, Branded and Patented in Spain in 2000, is Now Being Imitated http://www.prnewswire.co.uk/cgi/news/release?id=271108 2009-11-06T10:00:00+0000 NIGHTBRA, der erste Antifalten-BH einer spanischen Marke und mit spanischem Patent seit dem Jahr 2000, wird bereits imitiert http://www.prnewswire.co.uk/cgi/news/release?id=271110 2009-11-06T10:00:00+0000 NIGHTBRA, le premier soutien-gorge antirides de marque et de brevet espagnol lancé en 2000, a déjà des imitateurs http://www.prnewswire.co.uk/cgi/news/release?id=271111 2009-11-06T10:00:00+0000 NIGHTBRA, el primer sujetador antiarrugas con marca y patente española desde el 2000, ya tiene imitadores http://www.prnewswire.co.uk/cgi/news/release?id=271112 2009-11-06T10:00:00+0000 Ortho Clinical Diagnostics Launches First-of-its-kind Remote Monitoring Center in Europe http://www.prnewswire.co.uk/cgi/news/release?id=271107 2009-11-06T09:56:00+0000 Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) http://www.prnewswire.co.uk/cgi/news/release?id=271098 2009-11-06T08:00:00+0000 Raptor Pharmaceutical Corporation meldet, dass Ergebnisse zu NGX426, einem neuartigen, nicht-opioiden, oralen Analgetikum, auf Neuropathieschmerzkonferenz vorgestellt werden http://www.prnewswire.co.uk/cgi/news/release?id=271084 2009-11-06T03:55:00+0000 Piani internazionali di marketing e vendita della Star Scientific per il prodotto nutraceutico CigRx(TM) in collaborazione con inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271081 2009-11-06T01:27:00+0000 Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts http://www.prnewswire.co.uk/cgi/news/release?id=271077 2009-11-05T23:08:00+0000 Star Scientific prévoit de réaliser le marketing et la vente mondiaux du nutraceutique CigRx(TM) en partenariat avec inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271068 2009-11-05T20:59:00+0000 Star Scientific plant internationale marketing en verkoop van nutraceuticum CigRx(TM) in samenwerking met inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271065 2009-11-05T20:13:00+0000 Search Recent Search PR Newswire's archived press releases from the last three working days. SEARCH http://199.230.26.105/fulltext